Home Cart 0 Sign in  
X

[ CAS No. 161975-39-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 161975-39-9
Chemical Structure| 161975-39-9
Chemical Structure| 161975-39-9
Structure of 161975-39-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 161975-39-9 ]

Related Doc. of [ 161975-39-9 ]

Alternatived Products of [ 161975-39-9 ]

Product Details of [ 161975-39-9 ]

CAS No. :161975-39-9 MDL No. :MFCD02082459
Formula : C12H23NO5S Boiling Point : -
Linear Structure Formula :- InChI Key :RXNQBVRCZIYUJK-UHFFFAOYSA-N
M.W : 293.38 Pubchem ID :2765838
Synonyms :

Calculated chemistry of [ 161975-39-9 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.92
Num. rotatable bonds : 6
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 76.26
TPSA : 81.29 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.96
Log Po/w (XLOGP3) : 1.28
Log Po/w (WLOGP) : 2.31
Log Po/w (MLOGP) : 1.21
Log Po/w (SILICOS-IT) : 0.38
Consensus Log Po/w : 1.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.07
Solubility : 2.5 mg/ml ; 0.00852 mol/l
Class : Soluble
Log S (Ali) : -2.59
Solubility : 0.76 mg/ml ; 0.00259 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.72
Solubility : 5.54 mg/ml ; 0.0189 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.88

Safety of [ 161975-39-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 161975-39-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 161975-39-9 ]

[ 161975-39-9 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 161975-39-9 ]
  • [ 145508-94-7 ]
YieldReaction ConditionsOperation in experiment
2.19 g With sodium iodide In acetoneReflux To tert-butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate (2.57 g, 8.8 mmol) in acetone (60 mL) was added sodium iodide (2.63 g, 17.5 mmol). The yellow solution formed was heated at reflux overnight. The resulting orange suspension formed was cooled to room temperature and filtered. The filtrate was concentrated in vacuo and the residue partitionedbetween DCM (100 ml) and water (20 ml). The organic portion was dried (MgSO4) and treated with silica (10 g). This was filtered and the filtrate concentrated to give the title compound as an orange oil (2.19 g);1H NMR (400MHz, ODd3) o 1.14 (2H, dq), 1.48 (9H, 5), 1.57-1.70 (1H, m), 1.82-1.90 (2H, m), 2.73 (2H, t), 3.12 (2H, d), 4.10-4.20 (2H, m).
Reference: [1] Patent: US2002/13348, 2002, A1,
[2] Patent: EP2017275, 2009, A1, . Location in patent: Page/Page column 53
[3] Patent: WO2015/8230, 2015, A1, . Location in patent: Page/Page column 303
  • 2
  • [ 161975-39-9 ]
  • [ 158407-04-6 ]
YieldReaction ConditionsOperation in experiment
85.4% With lithium bromide In acetoneReflux Amixture of 2 (1eq, 11.72 g, 40 mmol) and lithium bromide (5eq,17.20 g, 200 mmol) in acetone (80 mL) was heated to reflux overnight.The mixture was evaporated, then the residue was partitionedbetween EtOAc and water. The organic layer was washedwith s brine, dried over Na2SO4, filtered, and evaporated to offer the title product 3 as pale yellow oil (9.46 g, 85.40percent yield).
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 145, p. 96 - 112
  • 3
  • [ 773837-37-9 ]
  • [ 161975-39-9 ]
  • [ 256411-39-9 ]
YieldReaction ConditionsOperation in experiment
6.87 g at 80℃; for 24 h; 4-(cyanomethyl)piperidine-1-carboxylate
tert-Butyl 4-[(methylsulfonyl)oxy]methyl}piperidine-1-carboxylate (15.3 g) was dissolved in ethanol (80 mL), water (20 mL) and sodium cyanide (4.0 g, 80 mmol) were added, and stirring was conducted at 80° C. for 24 hours.
Ethanol was distilled off, water and ethyl acetate were added, and then the resultant mixture was subject to Celite filtration, followed by extraction with ethyl acetate.
The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate and concentrated under a reduced pressure, and the obtained residue was purified by using silica gel column chromatography (hexane:ethyl acetate=3:1→2:1) to give tert-butyl 4-(cyanomethyl)piperidine-1-carboxylate (6.87 g, 77percent, 3 steps) as a white solid.
1H-NMR (CDCl3) δ: 1.21-1.31 (2H, m), 1.46 (9H, s), 1.78-1.86 (3H, m), 2.31 (2H, d, J=6.4 Hz), 2.64-2.78 (2H, m), 4.07-4.21 (2H, m).
Reference: [1] Patent: US2013/102621, 2013, A1, . Location in patent: Paragraph 0281; 0282
  • 4
  • [ 161975-39-9 ]
  • [ 256411-39-9 ]
Reference: [1] Patent: WO2004/54973, 2004, A2, . Location in patent: Page 38
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 161975-39-9 ]

Amides

Chemical Structure| 141699-59-4

[ 141699-59-4 ]

tert-Butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.91

Chemical Structure| 129888-60-4

[ 129888-60-4 ]

tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 404577-34-0

[ 404577-34-0 ]

(R)-1-N-Boc-3-Methanesulfonyloxypiperidine

Similarity: 0.89

Chemical Structure| 940890-90-4

[ 940890-90-4 ]

(S)-tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 141699-57-2

[ 141699-57-2 ]

tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.82

Sulfonates

Chemical Structure| 141699-59-4

[ 141699-59-4 ]

tert-Butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.91

Chemical Structure| 129888-60-4

[ 129888-60-4 ]

tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 404577-34-0

[ 404577-34-0 ]

(R)-1-N-Boc-3-Methanesulfonyloxypiperidine

Similarity: 0.89

Chemical Structure| 940890-90-4

[ 940890-90-4 ]

(S)-tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 141699-57-2

[ 141699-57-2 ]

tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.82

Related Parent Nucleus of
[ 161975-39-9 ]

Piperidines

Chemical Structure| 141699-59-4

[ 141699-59-4 ]

tert-Butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.91

Chemical Structure| 129888-60-4

[ 129888-60-4 ]

tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 404577-34-0

[ 404577-34-0 ]

(R)-1-N-Boc-3-Methanesulfonyloxypiperidine

Similarity: 0.89

Chemical Structure| 940890-90-4

[ 940890-90-4 ]

(S)-tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.89

Chemical Structure| 123855-51-6

[ 123855-51-6 ]

tert-Butyl 4-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.71